Acura Targets 4 Rivals Over Generic Oxecta Plans
Acura Pharmaceuticals Inc. hit four rivals with patent infringement suits in Delaware federal court Wednesday, seeking to block their plans to market generic versions of opioid painkiller Oxecta....To view the full article, register now.
Already a subscriber? Click here to view full article